SELLAS Life Sciences Group, Inc. (SLS) Misses Q3 EPS by 35c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.33), $0.35 worse than the analyst estimate of $0.02.

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick
• MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance